North Bay Neuroscience Institute

Prior to being notified of the cessation of testing for potential Alzheimer drugs, our work involved researching different potential medicines that may impact the onset of Alzheimers Disease. We worked with pharmaceutical companies which are in various trial stages of developing these new drugs. Our job was to work with patient subjects who had early Alzheimer indications and wanted to try these trial drugs. Their participation in these studies helped us all understand ways to beat Alzheimers Disease.